End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
5.29
CNY
|
-2.58%
|
|
-1.86%
|
-24.10%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,044
|
4,047
|
7,040
|
10,508
|
5,346
|
4,740
|
Enterprise Value (EV)
1 |
4,542
|
3,950
|
7,169
|
11,099
|
6,375
|
5,911
|
P/E ratio
|
12.5
x
|
11.8
x
|
17.7
x
|
29.7
x
|
786
x
|
-15.5
x
|
Yield
|
5.58%
|
5.95%
|
3.43%
|
2.21%
|
-
|
-
|
Capitalization / Revenue
|
0.54
x
|
0.64
x
|
1.23
x
|
1.56
x
|
0.95
x
|
1.24
x
|
EV / Revenue
|
0.61
x
|
0.63
x
|
1.26
x
|
1.65
x
|
1.13
x
|
1.55
x
|
EV / EBITDA
|
6.29
x
|
5.77
x
|
9.56
x
|
18.2
x
|
24.7
x
|
-137
x
|
EV / FCF
|
11.8
x
|
6.55
x
|
34.7
x
|
-37.2
x
|
1,316
x
|
45.4
x
|
FCF Yield
|
8.46%
|
15.3%
|
2.89%
|
-2.69%
|
0.08%
|
2.2%
|
Price to Book
|
1.31
x
|
1.26
x
|
2.16
x
|
3.05
x
|
1.65
x
|
1.61
x
|
Nbr of stocks (in thousands)
|
673,920
|
674,560
|
675,634
|
680,098
|
680,098
|
680,098
|
Reference price
2 |
6.000
|
6.000
|
10.42
|
15.45
|
7.860
|
6.970
|
Announcement Date
|
4/29/19
|
4/24/20
|
4/19/21
|
4/28/22
|
4/18/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,449
|
6,288
|
5,708
|
6,717
|
5,639
|
3,813
|
EBITDA
1 |
722.5
|
684
|
749.5
|
608.4
|
258.1
|
-43.02
|
EBIT
1 |
509
|
462.5
|
522.6
|
376.6
|
10.74
|
-301.2
|
Operating Margin
|
6.83%
|
7.35%
|
9.16%
|
5.61%
|
0.19%
|
-7.9%
|
Earnings before Tax (EBT)
1 |
406.4
|
431.8
|
514.4
|
419.7
|
22.63
|
-350
|
Net income
1 |
325.7
|
346.7
|
402.7
|
352.2
|
5.595
|
-308.9
|
Net margin
|
4.37%
|
5.51%
|
7.05%
|
5.24%
|
0.1%
|
-8.1%
|
EPS
2 |
0.4800
|
0.5100
|
0.5900
|
0.5200
|
0.0100
|
-0.4500
|
Free Cash Flow
1 |
384.5
|
603.5
|
206.9
|
-298.2
|
4.843
|
130.3
|
FCF margin
|
5.16%
|
9.6%
|
3.62%
|
-4.44%
|
0.09%
|
3.42%
|
FCF Conversion (EBITDA)
|
53.21%
|
88.22%
|
27.6%
|
-
|
1.88%
|
-
|
FCF Conversion (Net income)
|
118.05%
|
174.07%
|
51.37%
|
-
|
86.56%
|
-
|
Dividend per Share
2 |
0.3350
|
0.3570
|
0.3570
|
0.3420
|
-
|
-
|
Announcement Date
|
4/29/19
|
4/24/20
|
4/19/21
|
4/28/22
|
4/18/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
499
|
-
|
129
|
591
|
1,029
|
1,171
|
Net Cash position
1 |
-
|
97.2
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.6903
x
|
-
|
0.1722
x
|
0.9721
x
|
3.988
x
|
-27.22
x
|
Free Cash Flow
1 |
384
|
603
|
207
|
-298
|
4.84
|
130
|
ROE (net income / shareholders' equity)
|
10.6%
|
10.8%
|
12.5%
|
10.3%
|
0.53%
|
-9.03%
|
ROA (Net income/ Total Assets)
|
5.34%
|
5.51%
|
6.21%
|
3.86%
|
0.1%
|
-3.16%
|
Assets
1 |
6,094
|
6,289
|
6,487
|
9,126
|
5,497
|
9,791
|
Book Value Per Share
2 |
4.570
|
4.770
|
4.820
|
5.070
|
4.770
|
4.320
|
Cash Flow per Share
2 |
1.070
|
0.6600
|
0.9400
|
0.9100
|
0.6000
|
0.6300
|
Capex
1 |
28.5
|
103
|
366
|
487
|
258
|
70
|
Capex / Sales
|
0.38%
|
1.64%
|
6.41%
|
7.24%
|
4.57%
|
1.84%
|
Announcement Date
|
4/29/19
|
4/24/20
|
4/19/21
|
4/28/22
|
4/18/23
|
4/22/24
|
|
1st Jan change
|
Capi.
|
---|
| -22.09% | 510M | | +18.32% | 67.02B | | +3.29% | 49.69B | | +19.55% | 42.41B | | +23.39% | 26.65B | | +12.11% | 19.62B | | +0.75% | 17.1B | | +3.27% | 15.64B | | -24.51% | 15.43B | | -9.92% | 15.3B |
Other Specialty Chemicals
|